K

Karolinska Development AB
STO:KDEV

Watchlist Manager
Karolinska Development AB
STO:KDEV
Watchlist
Price: 1.208 SEK 0.17% Market Closed
Market Cap: 322.9m SEK
Have any thoughts about
Karolinska Development AB?
Write Note

Intrinsic Value

The intrinsic value of one KDEV stock under the Base Case scenario is 1.672 SEK. Compared to the current market price of 1.208 SEK, Karolinska Development AB is Undervalued by 28%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

KDEV Intrinsic Value
1.672 SEK
Undervaluation 28%
Intrinsic Value
Price
K
Base Case Scenario

Valuation Backtest
Karolinska Development AB

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for KDEV cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about KDEV?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Pharmaceuticals Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Karolinska Development AB

Provide an overview of the primary business activities
of Karolinska Development AB.

What unique competitive advantages
does Karolinska Development AB hold over its rivals?

What risks and challenges
does Karolinska Development AB face in the near future?

Has there been any significant insider trading activity
in Karolinska Development AB recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Karolinska Development AB.

Provide P/S
for Karolinska Development AB.

Provide P/E
for Karolinska Development AB.

Provide P/OCF
for Karolinska Development AB.

Provide P/FCFE
for Karolinska Development AB.

Provide P/B
for Karolinska Development AB.

Provide EV/S
for Karolinska Development AB.

Provide EV/GP
for Karolinska Development AB.

Provide EV/EBITDA
for Karolinska Development AB.

Provide EV/EBIT
for Karolinska Development AB.

Provide EV/OCF
for Karolinska Development AB.

Provide EV/FCFF
for Karolinska Development AB.

Provide EV/IC
for Karolinska Development AB.

Show me price targets
for Karolinska Development AB made by professional analysts.

What are the Revenue projections
for Karolinska Development AB?

How accurate were the past Revenue estimates
for Karolinska Development AB?

What are the Net Income projections
for Karolinska Development AB?

How accurate were the past Net Income estimates
for Karolinska Development AB?

What are the EPS projections
for Karolinska Development AB?

How accurate were the past EPS estimates
for Karolinska Development AB?

What are the EBIT projections
for Karolinska Development AB?

How accurate were the past EBIT estimates
for Karolinska Development AB?

Compare the revenue forecasts
for Karolinska Development AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Karolinska Development AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Karolinska Development AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Karolinska Development AB compared to its peers.

Compare the P/E ratios
of Karolinska Development AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Karolinska Development AB with its peers.

Analyze the financial leverage
of Karolinska Development AB compared to its main competitors.

Show all profitability ratios
for Karolinska Development AB.

Provide ROE
for Karolinska Development AB.

Provide ROA
for Karolinska Development AB.

Provide ROIC
for Karolinska Development AB.

Provide ROCE
for Karolinska Development AB.

Provide Gross Margin
for Karolinska Development AB.

Provide Operating Margin
for Karolinska Development AB.

Provide Net Margin
for Karolinska Development AB.

Provide FCF Margin
for Karolinska Development AB.

Show all solvency ratios
for Karolinska Development AB.

Provide D/E Ratio
for Karolinska Development AB.

Provide D/A Ratio
for Karolinska Development AB.

Provide Interest Coverage Ratio
for Karolinska Development AB.

Provide Altman Z-Score Ratio
for Karolinska Development AB.

Provide Quick Ratio
for Karolinska Development AB.

Provide Current Ratio
for Karolinska Development AB.

Provide Cash Ratio
for Karolinska Development AB.

What is the historical Revenue growth
over the last 5 years for Karolinska Development AB?

What is the historical Net Income growth
over the last 5 years for Karolinska Development AB?

What is the current Free Cash Flow
of Karolinska Development AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Karolinska Development AB.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Karolinska Development AB

Current Assets 63.2m
Cash & Short-Term Investments 59.8m
Receivables 1.5m
Other Current Assets 1.9m
Non-Current Assets 1.2B
Long-Term Investments 1.2B
PP&E 2.7m
Current Liabilities 13.4m
Accounts Payable 1.3m
Accrued Liabilities 7.6m
Other Current Liabilities 4.5m
Efficiency

Earnings Waterfall
Karolinska Development AB

Revenue
1.9m SEK
Operating Expenses
-24.9m SEK
Operating Income
-23m SEK
Other Expenses
17.4m SEK
Net Income
-5.6m SEK

Free Cash Flow Analysis
Karolinska Development AB

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

KDEV Profitability Score
Profitability Due Diligence

Karolinska Development AB's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Negative Net Income
ROIC is Increasing
Positive Revenue Growth Forecast
Negative 3-Years Revenue Growth
36/100
Profitability
Score

Karolinska Development AB's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

KDEV Solvency Score
Solvency Due Diligence

Karolinska Development AB's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Karolinska Development AB's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KDEV Price Targets Summary
Karolinska Development AB

There are no price targets for KDEV.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for KDEV?

Click here to dive deeper.

Dividends

Karolinska Development AB
does not pay dividends
Shareholder Yield

Current shareholder yield for KDEV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

KDEV Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Karolinska Development AB

Country

Sweden

Industry

Pharmaceuticals

Market Cap

326m SEK

Dividend Yield

0%

Description

Karolinska Development AB engages in the investment in pharmaceutical and medical technology companies. The company is headquartered in Solna, Stockholm and currently employs 7 full-time employees. The company went IPO on 2011-04-15. The firm provides capital to biotechnology firms, as well as develops and commercializes biotechnological products. Its activities are involved in a range of areas: oncology, infections and wound healing, women’s health, cardiovascular and hematology, medical equipment, diagnostics, pharmaceutical formulation, as well as implants, among others. The Company’s pharmaceuticals portfolio comprises: AXL1717 for non-small-cell lung carcinoma (NSCLC), APR-246 for ovarian cancer, Sevuparin for malaria, SHACT for pain relief at hysteroscopy and intrauterine device (IUD) insertion, and PC-mAB for acute coronary syndrome (ACS), among others. Furthermore, the Company controls a number of subsidiaries, such as Avaris AB, HBV Thernostica AB, KD Incentive AB, KDev Oncology AB and Limone AB.

Contact

STOCKHOLM
Solna
Tomtebodavagen 23 A
+46852486070.0
www.karolinskadevelopment.com

IPO

2011-04-15

Employees

7

Officers

See Also

Discover More
What is the Intrinsic Value of one KDEV stock?

The intrinsic value of one KDEV stock under the Base Case scenario is 1.672 SEK.

Is KDEV stock undervalued or overvalued?

Compared to the current market price of 1.208 SEK, Karolinska Development AB is Undervalued by 28%.

Back to Top